Sydney, November 10, 2025 - RoseRx has strengthened its leadership team with two senior hires as it expands globally and deepens its use of AI to help life science companies engage patients and healthcare providers with hyper-personalization at scale.
Aurélie Cornu joins as Vice President of Marketing, bringing extensive experience in business to business software growth from previous roles at ASX-listed SiteMinder, Lighthouse and Goodstack. Rob Wise joins as VP of AI Engineering, charged with advancing RoseRx’s proprietary AI capabilities to enhance engagement intelligence.
“RoseRx is uniquely positioned at the intersection of healthcare, technology and innovation” said Cornu. “I’m excited to join at this pivotal time as we expand into new markets and scale our AI-driven solutions.”
CEO and Co-founder Romain Bonjean added:
“Aurelie and Rob strengthen our leadership as we accelerate our growth. Their expertise ensures we continue delivering intelligent, compliant engagement solutions that improve outcomes for patients, clinicians and life science partners.”
